|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Lantern Pharma (NASDAQ: LTRN) through any online brokerage.
The latest price target for Lantern Pharma (NASDAQ: LTRN) was reported by Colliers Securities on 2020-07-28. The analyst firm set a price target for 24.00 expecting LTRN to rise to within 12 months (a possible 67.36% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Lantern Pharma (NASDAQ: LTRN) is $14.34 last updated Fri Jan 15 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Lantern Pharma.
There is no upcoming split for Lantern Pharma.